At present, it has been found that IGF2BP2 expression is increased in AML, and a large number of studies have found that IGF2BP2 can be involved in regulating the stability of lncRNA and affecting its expression [14, 29, 30]. The gene discussed is IGF2BP2; the disease is acute myeloid leukemia.